Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2022 Aug;28(8):1542-1543.
doi: 10.1038/s41591-022-01917-w.

Long-acting agents for HIV treatment and prevention

Affiliations
Comment

Long-acting agents for HIV treatment and prevention

Linda-Gail Bekker. Nat Med. 2022 Aug.
No abstract available

PubMed Disclaimer

Comment on

  • Cabotegravir for the prevention of HIV-1 in women: results from HPTN 084, a phase 3, randomised clinical trial.
    Delany-Moretlwe S, Hughes JP, Bock P, Ouma SG, Hunidzarira P, Kalonji D, Kayange N, Makhema J, Mandima P, Mathew C, Spooner E, Mpendo J, Mukwekwerere P, Mgodi N, Ntege PN, Nair G, Nakabiito C, Nuwagaba-Biribonwoha H, Panchia R, Singh N, Siziba B, Farrior J, Rose S, Anderson PL, Eshleman SH, Marzinke MA, Hendrix CW, Beigel-Orme S, Hosek S, Tolley E, Sista N, Adeyeye A, Rooney JF, Rinehart A, Spreen WR, Smith K, Hanscom B, Cohen MS, Hosseinipour MC; HPTN 084 study group. Delany-Moretlwe S, et al. Lancet. 2022 May 7;399(10337):1779-1789. doi: 10.1016/S0140-6736(22)00538-4. Epub 2022 Apr 1. Lancet. 2022. PMID: 35378077 Free PMC article. Clinical Trial.
  • Capsid Inhibition with Lenacapavir in Multidrug-Resistant HIV-1 Infection.
    Segal-Maurer S, DeJesus E, Stellbrink HJ, Castagna A, Richmond GJ, Sinclair GI, Siripassorn K, Ruane PJ, Berhe M, Wang H, Margot NA, Dvory-Sobol H, Hyland RH, Brainard DM, Rhee MS, Baeten JM, Molina JM; CAPELLA Study Investigators. Segal-Maurer S, et al. N Engl J Med. 2022 May 12;386(19):1793-1803. doi: 10.1056/NEJMoa2115542. N Engl J Med. 2022. PMID: 35544387 Clinical Trial.

Similar articles

References

    1. Stevens, G. L. et al. Early Intervention Psych. 10, 365–377 (2016). - DOI
    1. Segal‑Maurer, S. et al. N. Engl. J. Med. 386, 1793–1803 (2022). - DOI
    1. Delany-Moretlwe, S. et al. Lancet 399, 1779–1789 (2022). - DOI
    1. US Food and Drug Administration. https://www.fda.gov/drugs/human-immunodeficiency-virus-hiv/fda-approves-... (accessed June 2022).
    1. Dvory-Sobol, H., Shaik, N., Callebaut, C. & Rhee, M. S. Curr. Opin. HIV AIDS 17, 15–21 (2022). - DOI

MeSH terms

Substances

LinkOut - more resources